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Abstract: 
 
Background: Urinary tract infection (UTI) remains the second commonest opportunistic infections among HIV 
infected children. This study was conducted to determine the prevalence and causative bacteria of UTI in HIV 
infected children and adolescents on antiretroviral medications in our health institution.  
Method: The study was a cross sectional design conducted between October 2017 and March 2018 among HIV 
infected children and adolescents aged 2 months to 18 years on follow up attendance at the Paediatric Outpatient 
Special Treatment Clinic (POSTC) of University of Abuja Teaching Hospital (UATH). Early morning midstream urine 
was collected from each participant for urinalysis, microscopy and aerobic bacterial culture. Bacteria were identified 
from culture by standard microbiological methods and antibiogram of the isolates was determined by the disk 
diffusion method. 
Result: Of 166 HIV infected children and adolescents studied, 106 (63.9%) were males, 82 (49.4%) were in age 
group 5-10 years, and 110 (66.3%) were from lower socio-economic class. Significant bacteria (UTI) were isolated 
in 54 (32.5%) subjects, with 38 (70.4%) from females, and 51 (94.4%) from those on first line antiretroviral 
therapy. Isolates recovered were Escherichia coli 20 (37.0%), Klebsiella pneumoniae 16 (29.6%), Staphylococcus 
aureus 8 (14.8%), Pseudomonas aeruginosa 6 (11.1%), and Proteus mirabilis 4 (7.4%). Leucocyturia in 19 
(35.2%), nitrituria in 10 (18.5%), and haematuria in 15 (27.8%) subjects with significant bacteriuria were also 
recorded. Isolates were sensitive to ofloxacin (81.5%), nalidixic acid (74.1%) and cefuroxime (61.1%), while they 
were resistant to cotrimoxazole (100%), ampicillin (98.1%) and piperacillin (94.4%). Significant difference was 
observed in the mean CD4 cell count and viral load of subjects with significant bacteriuria compared to those 
without; 838.6 ± 177.8 versus 1009.9 ± 234.7 cells/μL (p=0.02), and 10, 360.5 ± 471.0 versus 5, 840.8 ± 563.8 
copies/ml (p=0.003) for CD4 cell count and viral load respectively. 
Conclusion: This study reported a high prevalence of UTI among HIV infected children and adolescents, especially 
in those with high viral load. Routine screening for UTI should be offered to HIV infected children and adolescents 
with high viral load.  
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Contexte: L’infection des voies urinaires (UTI) reste la deuxième infection opportuniste la plus répandue chez les 
enfants infectés par le VIH. Cette étude a été menée pour déterminer la prévalence et la bactérie causale des 
infections urinaires chez les enfants et les adolescents infectés par le VIH prenant des antirétroviraux dans notre 
établissement de santé.                    
Méthode: L'étude était une conception transversale menée entre octobre 2017 et mars 2018 chez des enfants et 
des adolescents infectés par le VIH âgés de 2 mois à 18 ans et suivis à la Clinique de traitement spécial pour 
enfants ambulatoires (POSTC) de l'Hôpital universitaire de Abuja (UATH) ). Des échantillons d'urine, de microscopie 
et de cultures bactériennes aérobies ont été recueillis chez chaque participant. Les bactéries ont été identifiées à 
partir de cultures par des méthodes microbiologiques standard et l'antibiogramme des isolats a été déterminé par 
la méthode de diffusion sur disque.                     
Résultat: Sur 166 enfants et adolescents infectés par le VIH étudiés, 106 (63,9%) étaient des hommes, 82 
(49,4%) étaient âgés de 5 à 10 ans et 110 (66,3%) appartenaient à la classe socio-économique inférieure. Des 
bactéries significatives (UTI) ont été isolées chez 54 sujets (32,5%), dont 38 (70,4%) de femmes et 51 (94,4%) 
de celles sous traitement antirétroviral de première intention. Les isolats récupérés étaient Escherichia coli 20 
(37,0%), Klebsiella pneumoniae 16 (29,6%), Staphylococcus aureus 8 (14,8%), Pseudomonas aeruginosa 6 
(11,1%) et Proteus mirabilis 4 (7,4%). Une leucocyturie chez 19 sujets (35,2%), une nitriturie chez 10 (18,5%) et 
une hématurie chez 15 sujets (27,8%) présentant une bactériurie importante ont également été enregistrés. Les 
isolats étaient sensibles à l'ofloxacine (81,5%), à l'acide nalidixique (74,1%) et au céfuroxime (61,1%), tandis 
qu'ils étaient résistants au cotrimoxazole (100%), à l'ampicilline (98,1%) et à la pipéracilline (94,4%). Une 
différence significative a été observée entre le nombre moyen de cellules CD4 et la charge virale des sujets 
présentant une bactériurie significative par rapport à ceux ne présentant pas; 838,6 ± 177,8 par rapport à 1009,9 
± 234,7 cellules/μL (p = 0,02) et 10, 360,5 ± 471,0 par rapport à 5 840,8 ± 563,8 copies/ml (p = 0,003) pour le 
nombre de cellules CD4 et la charge virale, respectivement.                
Conclusion: Cette étude a révélé une prévalence élevée d’UTI chez les enfants et les adolescents infectés par le 
VIH, en particulier chez ceux ayant une charge virale élevée. Un dépistage systématique des infections urinaires 
doit être proposé aux enfants et aux adolescents à charge virale élevée infectés par le VIH 
Mots-clés: VIH, infection des voies urinaires, enfants, adolescents 
Introduction: 
 
 Globally over 3.4 million children are 
living with human immunodeficiency virus 
(HIV) infection at the end of 2011, 91% of 
which are in sub-Saharan Africa, which harbors 
only 10% of the world’s population (1, 2). 
Kidney disease is a widely recognized frequent 
complication of HIV infection and often 
manifests as HIV associated nephropathy 
(HIVAN), urinary tract infections (UTI), 
electrolyte abnormalities, among others (3, 4). 
UTI is defined as the presence of bacterial 
growth of greater than 105 colony forming 
units per ml in a clean-catch, mid-stream 
voided urine sample, or greater than 103 
organisms per ml in a catheter or supra-pubic 
aspirated urine. UTI is the second most 
common infection in children (5).  
 Urinary tract is a unique sterile space 
lined with transitional mucosa cells and usually 
impermeable to microorganisms. However, 
infection occurs when pathogenic organisms 
enter the space and subsequently adhere to its 
mucosal lining (5). The mechanisms of 
entrance are either through retrograde ascent 
of fecal-perineal bacteria from the host bowel 
or nosocomial following instrumentation, or as 
part of a systemic infection (5, 6). Gender, 
age, race, circumcision, and immune status of 
individuals are host factors that affect the 
incidence and bacterial adherence in UTI (5, 
6).  
 Notable urinary pathogens causing UTI 
include Gram-negative rods (Escherichia coli, 
Citrobacter spp, Enterobacter spp), Gram-
negative cocci (Neisseria gonorrheae), Gram-
positive cocci (Staphylococcus aureus, 
Staphylococcus saprophyticus), and other 
pathogens such as Candida albicans, and 
Chlamydia trachomatis (5, 6). This risk of UTI 
is high in women, infants, elderly, and people 
with spinal cord injuries, urinary catheters, 
diabetes, immunodeficiency, and underlying 
urologic abnormalities (7, 8, 9, 10).  
 The hallmark of HIV infection is the 
profound immunosuppression that results from 
continued depletion of CD4 cells. This immune 
deficient state predisposes the individual to a 
wide variety of opportunistic infections (OIs) 
and renal syndromes that causes neurologic 
complications leading to urinary stasis and 
ultimately UTI (11,12). The incidence of UTI in 
HIV population is clearly related to infection 
and immune function, as determined by 
lymphocytes CD4+ cells count. UTI is one of 
the most common bacterial infections 
associated with morbidity and hospitalization in 
HIV infected individuals (13).  
 Available literature on UTI and 
HIV/AIDS however showed conflicting reports, 
 




with some authors reporting higher frequency 
of UTI among HIV cohorts especially adult 
population, (14,15) while others reported no 
significant impact of the disease on the 
incidence of UTI (16,17). Asharam et al., (16) 
found no significant impact of HIV/AIDS on 
bacterial UTI among infected children aged 0–
12 years in South Africa, which was similar to 
the report of O’Regan et al., (17).in Canada. 
However in Nigeria, Ibadin et al., reported high 
frequency of UTI in adolescent and young adult 
patients with advanced WHO clinical stages 
(18). Kaplan et al., (15) also reported high 
incidence of UTI (20.0%) among his AIDS 
cohort.  
 Because of paucity of information on 
incidence of UTI among HIV children in this 
part of the country, this study was conducted 
to determine the prevalence and aetiological 
agents of UTI among HIV-infected children and 
adolescents on highly active antiretroviral 
therapy (HAART) at a tertiary health institution 
in Abuja, Nigeria, with the aim that these 
findings will provide insight on the magnitude 
of the problem among infected children and 
adolescents in our environment. 
 
Methodology: 
Study setting and design                         
 A cross sectional study was carried out 
at the Paediatric Outpatient Special Treatment 
Clinic (POSTC) of the University of Abuja 
Teaching Hospital (UATH) between October 
2017 to March 2018. POSTC is an out-patient 
clinical service area where HIV infected 
children and exposed babies are seen and 
followed up for treatment/monitoring. It has 
consulting rooms for the doctors, nurses, and 
adherence counselors. Record clerks, Pharma- 
cists and nutritionists are also at their disposal 
on week days (Monday-Friday, from 7.30 am 
to 4 pm.).      
 UATH is a 350 bed capacity referral 
hospital, sub-serving the people of Federal 
Capital Territory, Abuja and five neighbouring 
states. It is one of the first centers to start 
offering free HIV/AIDS services in the country 
in 2005, through the President Emergency Plan 
for AIDS Relief (PEPFAR).  
Subjects                  
 The subjects were paediatric HIV 
infected patients between the ages 2 months 
and 18 years diagnosed either by serological 
method or by polymerase chain reaction (PCR) 
test, and started on anti-retroviral (ARV) 
therapy. Consecutive eligible children attending 
the POSTC were recruited and subsequently 
enrolled into the study after parents/caregivers 
provided written informed consent, and 
children 7 years and above provided written 
inform assent.    
 Inclusion criteria for the study were; 
HIV infected children and adolescents from 2 
months to 18 years of age on ARV therapy, 
patients/caregivers/children residing within 
FCT Abuja for easy collection of early morning 
urine, parents/caregivers acceptance to be part 
of the study, and older children who gave 
assent for the study. Exclusion criteria include 
those unwilling to participate in the study, 
exposed babies, those residing outside FCT, 
and patients with other forms of nephropathy 
such as nephrotic syndrome, acute glomerulo- 
nephritis and others. Ethical clearance was 
obtained from the Ethics Committee of the 
health institution before the commencement of 
the study.   
Specimen collection 
 Clinical and physical examinations were 
carried out on each subject after enrollment by 
the attending physician. All the subjects were 
then given plastic universal sterile transparent 
container with screw cap, and oral and written 
instructions were provided for each subject or 
their parents/guardians on the method of urine 
collection.     
 Early morning clean catch specimens of 
midstream voided urine were collected. For the 
female subjects, they were instructed to clean 
their genitalia from anterior to posterior in a 
unidirectional manner with the labial held 
apart, and for the infants, the parent/caregiver 
were advised to hold the child on the laps with 
the genitals exposed prior to collection. The 
urine samples were delivered to the laboratory 
within one hour of collection.   
 Blood sample was also collected for 
CD4+ T-cell (CD4) and viral load (VL) 
estimation from those subjects who have not 
had these estimated in the last 3 months 
preceding the study.  
 
Bacterial cultures and identification 
 Each urine specimen was first 
examined macroscopically and then divided 
into two equal volumes. The first was used for 
urinalysis and Gram’s staining, while the 
second volume was centrifuged at 3000 rpm 
for 5 minutes, and used for urine microscopy 
and inoculation of Blood and Cysteine Lactose 
Electrolyte Deficient (CLED) agar plates. 
Calibrated wire loop delivering 0.002 ml of the 
centrifuged urine was used to inoculate the 
 




culture media. The cultures were incubated at 
37oC for 18-24 hours aerobically. After 
overnight incubation, colony number and 
characteristics on the agar plates were 
determined, and then Gram stained. Colonies 
that were Gram positive on CLED were further 
characterized using conventional biochemical 
scheme of catalase, coagulase and novobiocin 
disc tests, while those with Gram negative 
reaction were characterized using the indole, 
motility, methyl red, Voges-Proskauer and 
citrate utilization (iMMVPC) tests.  
 The presence of at least one Gram 
positive or negative bacteria per oil-immersion 
field in the uncentrifuged urine or colony count 
of greater than 105 CFU/ml of urine from the 
overnight culture on Blood agar plate was 
considered significant bacteriuria. Positive 
nitrite on urinalysis and presence of pus cells 
were considered features suggestive of UTI.   
 
Antibiotic susceptibility testing  
 Antibiotic susceptibility of each isolate 
along with control strains (Staphylococcus 
aureus ATCC 29213, Escherichia coli ATCC 
25922, Pseudomonas aeruginosa ATCC 27853 
and Enterococcus faecalis ATCC 29212) was 
determined using the Muller-Hinton agar media 
by the disk diffusion method. Three to five 
pure colonies of similar appearance of each 
isolate and the control strains were emulsified 
in 4 ml sterile saline. The inoculum suspension 
was standardized by comparing the turbidity 
with 0.5 McFarland standards. Muller-Hinton 
agar plate was streaked with the inoculum 
suspension using sterile swab, and antibiotic 
discs were placed on each agar plate after 5 
minutes using sterile forcep. Within 30 minutes 
of applying the discs, the plates were 
incubated at 35oC for 18 to 24 hours, following 
which the test and the control agar plates were 
examined, and the diameters of zone of 
inhibition (in mm) were measured with a ruler. 
 The zone diameters of inhibition of the 
antibiotics for the control strain were first 
compared with the CLSI standards and if within 
the acceptable limits, the zone diameters for 
the test isolates were then compared with CLSI 
zone diameter breakpoints, and result 
interpreted as sensitive, intermediate or 
resistance. 
 
CD4 cell count & viral load estimation
 The CD4 cell count was measured 
using automated Partec Cyflow easy count kit 
(Partec code no. 05-8401, Western Germany), 
and viral load (VL) measurement was done 
with Roche Smp/prep/cobs Taqman 96, USA. 
 
Data analysis    
 Data were analysed using SPSS version 
21.0 and results presented in frequency tables, 
percentages, means and standard deviations. 
The test for association between variables was 
done with the student t-test. A p value < 0.05 
was considered significant.  
Results:  
 Table 1 shows the demographic 
distribution of the 166 subjects, comprising 
106 (63.9%) males, 82 (49.4%) in age group 
5-<10 years, 114 (68.7%) were Christian, 110 
(66.3%) from low socio-economic class, and 
142 (85.5%) on 1st line ART. The mean CD4 
cell count was 894.5±449.1 cells/μl, and mean 
VL was 9,136.1±306.0 copies/ml. 
 The characteristic of the study 
population with and without isolates is shown 
in Table 2. Bacteria were isolated from urine of 
54 (32.5%) subjects; Escherichia coli in 20 
(37.0%), Klebsiella pneumoniae 16 (29.6%), 
Staphylococcus aureus 8 (14.8%), Pseudo- 
monas aeruginosa 6 (11.1%), and Proteus 
mirabilis 4 (7.4%). Leucocyturia, nitrituria, and 
haematuria were reported in 19 (35.2%), 10 
(18.5%), and 15 (27.8%) subjects with urinary 
bacterial isolates respectively.   
 Sixteen (29.6%) isolates were reco- 
vered from subjects in age group 10-15 years, 
38 (70.4%) from females, 36 (66.7%) from 
Christians, and 31 (57.4%) from subjects in 
low socio economic class. There was no 
significant difference in socio-economic status 
(p=0.303), age group (p=0.744), religion 
(p=0.699), and leucocyturia, nitrituria or 
haematuria (p=0.64) between subjects with 
urinary isolates and those without isolates. 
There was however a significant difference in 
the CD4 cell count (838.6±177.8 vs 
1009.9±234.7 cells/μl, p=0.02) and viral load 
(10,360.5±471.0 vs 5,840.8±563.8 copies/ml, 
p=0.003) between subjects with urinary 
isolates compared to those without isolates, 
and subjects on 1st and 2nd line medication 
(p=0.024), and gender (p=0.03).  
      
 
 




Table 1: Demographic and clinical characteristics of the study population 
Characteristics 
 










Age group (years)    
 <5 7 (53.8) 6 (46.2) 13 (7.8) 









Religion    
 Christianity 78 (68.4) 36 (31.6) 114 (68.7) 
 Islam 28 (53.8) 24 (46.2) 52 (31.3) 
Socioeconomic class     
 High 15 (68.2) 7 (31.8) 22 (13.3) 
 Middle 24 (70.6) 10 (29.4) 34 (20.4) 
 Low 67 (60.9) 43 (39.1) 110 (66.3) 
ARVT    
 1st line 92 (64.8) 50 (35.2) 142 (85.5) 
 2nd line 14 (58.3) 10 (41.7) 24 (14.5) 
Weight, CD4 and Viral Load 
 Weight (kg) 
 CD4 (cells/μl) 














ARVT = Anti-retroviral therapy; *Values are mean ±SD  



















Age group (years)     
 <5 4 (7.4) 9 (8.0) 13 (7.8) 0.744 
 5-<10 13 (24.1) 55 (49.1) 82 (49.4)  
 10-15 16 (29.6) 39 (34.8) 55 (33.1)  
 > 15 7 (13.0) 9 (8.0) 16 (9.6)  
Gender     
 Male 16 (29.6) 90 (80.4) 106 (63.8) 0.031 
 Female 38 (70.4) 22 (19.6) 60 (36.2)  
Religion     
 Christianity 36 (66.7) 78 (69.6) 114 (68.7) 0.699 
 Islam 18 (33.3) 34 (30.4) 50 (31.3)  
Socioeconomic status     
 High 9 (16.7) 13 (11.6) 22 (13.3) 0.303 
 Middle 14 (25.9) 20 (17.9) 34 (20.4)  
 Low 31 (57.4) 79 (70.5) 110 (66.3)  
ARVT     
 1st line 51 (94.4) 91 (81.3) 142 (85.5) 0.024 
 2nd line 3 (5.6) 21 (18.8) 24 (14.5)  














































































Table 3: Antibiotic susceptibility of isolates from subjects with urinary tract infection 
Antibiotic 
sensitivity  
E. coli (%) 
(n = 20) 
K. pneumoniae (%) 
(n=16) 
S. aureus (%) 
(n = 8) 
Ps. aeruginosa (%) 
(n=6) 
P. mirabilis (%) 
(n=4) 
Total (%) 
(n = 54)  
Ofloxacin 18 (90) 14 (87.5) 7 (87.5) 5 (83.3) 3 (75) 44 (81.5) 
Augmentin 3 (15) 7 (43.8) 2 (25) 3 (50.0) 3 (50) 19 (35.2) 
Cefuroxime 12 (60) 11 (68.8) 5 (62.5) 4 (66.7) 1 (25) 33 (61.1) 
Nalidixic acid 15 (83.3) 12 (75) 6 (75.5) 5 (83.3) 2 (50) 40 (74.1) 
Gentamicin 9 (45) 7 (43.8) 3 (37.5) 2 (33.3) 2 (50) 23 (42.6) 
Tetracycline 0 0 0 0 0 0 
Antibiotic 
resistance 
      
Cotrimoxazole 20 (100) 16 (100) 8 (100) 6 (100) 4 (100) 54 (100) 
Ampicillin 19 (95) 16 (100) 8 (100) 6 (100) 4 (100) 53 (98.1) 
Amoxycillin 18 (90) 15 (93.8) 8 (100) 6 (100) 3 (75) 50 (92.6) 
Erythromycin 16 (80) 12 (75.0) 7 (87.6) 5 (83.3) 3 (75) 43 (79.6) 
Piperacillin 20 (100) 15 (93.8) 8 (100) 4 (66.7) 4 (100) 51 (94.4) 
 
 The susceptibility patterns of the 
isolates are shown in Table 3. While ofloxacin, 
nalidixic acid and cefuroxime were the most 
effective antibiotics invitro with 44 (81.5%), 40 
(74.1%), and 33 (61.1%) of the isolates 
respectively sensitive to them, augmentin and 
tetracycline were the least effective with 19 
(35.2%) and 0 (100%) isolates respectively, 
sensitive to them. The isolates were largely 
resistant to cotrimoxazole 54 (100%), 
ampicillin 53 (98.1%), and piperacillin 51 
(94.4%).    
 Ofloxacin was the most effective 
antibiotic invitro with 18 (90.0%) E. coli, 14 
(87.5%) K. pneumoniae, and 7 (87.5%) S. 
aureus isolates sensitive to it. Tetracycline was 
the least effective with no isolate sensitive to 
it, while 9 (45.0%) E. coli, 7 (43.8%) K. 
pneumoniae, 3 (37.5%) S. aureus, 2 (33.3%) 
Ps. aeruginosa, and 2 (50.0%) P. mirabilis were 
sensitive to gentamicin.  
Discussion: 
 This study shows a high prevalence 
rate of 32.5% for UTI among HIV-infected 
children and adolescents on follow up visit to 
the Paediatric Outpatient Special Treatment 
Clinic of University of Abuja Teaching Hospital, 
Abuja, Nigeria. This was far lower than 96.6% 
reported among HIV infected children aged 0-
12 years in South Africa by Asharam et al., 
(16). The difference between the two studies 
might be due to the study design and nature of 
the patients in the two groups. While the South 
African study was a retrospective one carried 
out among symptomatic hospital patients with 
culture-proven UTI, the present study was a 
cross sectional survey of HIV patients on 
outpatient routine clinic visit. The prevalence in 
our study was however comparable to figures 
obtained from HIV infected children and adults 
in other centers and other countries; 24.7% in 
children from Lagos (19), 22.2% among HIV 
children (20), 23.2% among adults in Poland 
(21), 48.7% among adults from South Africa 
(11), 40.4% among adults in Nigeria (22), and 
57.3% from another Nigerian study among 
adult population (23). The rate in our study 
was also higher than the rates reported from 
other studies among HIV infected children; 
9.5% from Zimbabwe (24), 16.8% from 
Jamaica (3), 13.2% from Romania (25), 6.3%, 
10.3% and 6.8% from other studies from 
Nigeria (18,26,27).     
 The high prevalence of UTI among HIV 
infected children and adolescents in this study 
require further evaluation for clinical 
significance. This is important because of 
attendant risk of developing renal scarring 
from pyelonephritis and long term complication 
of hypertension and chronic kidney disease. 
The reason for the high prevalence of UTI in 
this study might be due to the practice of 
discontinuation of chemoprophylaxis with co-
trimoxazole in HIV patients whose immunity 
has remarkably improved. This practice is 
common in other centers, and appeared logical 
as suggested by Imamura from Japan (28). 
Co-trimoxazole is generally recommended in 
HIV infected patients for prevention of opport- 
unistic infections (OIs). HAART is equally the 
most effective approach in prevention of OIs 
however, OIs are still occurring in patients on 
HAART, especially those who accessed care 
late (28). The late access to care might be the 
case of patients in this study which though 
showed a good immunological response (mean 
CD4 cell counts of 894.5±449.1 cells/μl) but 
still had evidence of UTI.  
 Subjects with isolates in their urine had 
significantly lower CD4 cell count and higher VL 
than those without isolates; 838.6±177.8 vs 
1009.9±234.7 cells/μl (p=0.02) for CD4 cell 
 




count, and 10,360.5± 471.0 vs 5,840.8±563.8 
copies/ml, (p=0.003) for VL. This is similar to 
findings of other studies where significantly 
lower CD4 cell count and WHO stage 3 and 4 
clinical disease consistent with high VL, was 
observed in infected children and adults with 
UTI (21, 29, 30). Iduoriyekemwen et al., (26) 
however did not make such observations 
among their study cohort in Nigeria. The 
reason for the significant difference in CD4 cell 
count and VL of those with and those without 
isolates in their urine might be related to late 
recognition of virological failure that may have 
occurred in those on 1st line ARV medications 
as subjects on 1st line drugs were observed to 
have significant isolates in their urine. 
Okechukwu and Amajuoyi (31) in their 9 year 
review of ART failure among HIV infected 
children in the same study center observed as 
much as 15.9% to have failed 1st line ART. This 
virological failure may go on for several years 
before immunological and clinical failures 
become evident with risk of OIs.  
 VL monitoring is the state-of-the-art 
monitoring of patients on ART. This test is to 
be done at least every 3-4 months after the 
initial test at diagnosis. Due to high cost, VL 
and resistant testing are not usually done in 
many HIV centers in resource limited settings 
like ours hence patients who fail virologically 
may be missed for a long time before they are 
switched to 2nd line medication. Recently 
though, regular VL monitoring has been 
institutionalized in our center.   
 Urinary pathogens were significantly 
isolated more in females than males (70.4% vs 
29.6%, p=0.031) in the present study. This is 
consistent with findings of other studies in both 
children and adults; 17.7% vs 7.0% among 
HIV children from Lagos (19), 75.0% vs 25.0% 
by Iduoriyekemwen et al., (26) in children 
from Benin, 42.8% vs 10.2% among un-
infected children from Lagos (32), 89.5% vs 
10.4% by Iweriobor et al., (12) among adults 
from South Africa, 90% vs 10% by Ibadin et 
al., (18) among adolescents and young adults 
in Nigeria, and 6.6% vs 4.8% among infected 
children and adults in Jos, Nigeria by Sheyin et 
al., (33). The reasons for higher prevalence of 
UTI in female subjects as previously 
established are related to short length of 
female urethra and the close proximity of 
vagina to anal orifice. This anatomical profile of 
female gender enhances retrograde ascent of 
fecal-perineal bacteria, increase peri-urethral 
colonization and easy contamination of enteric 
organisms from rectum to the urinary tract (5, 
6). Also absence of prostatic fluid in females 
which tend to decrease colonization in male 
because of its bacteriostatic property may also 
contribute to higher prevalence of UTI in 
females (6, 34). Decreased incidence of UTI in 
males could also be due to wide practice of 
circumcision in male especially among the 
Christian which formed 68.7% of the subjects 
in this study. This singular practice in males 
does not only reduce colonization of the 
urethral opening with enteric organisms, but 
also reduce the risk of UTI (25).   
 The frequency of isolated bacteria from 
urine in our study compared favourably with 
those from other HIV studies in both children 
and adults across the globe (12, 16-27). These 
uropathogens easily get access to the urinary 
space through retrograde ascent from the 
host’s bowel (5,6) but could also result from 
nosocomial cause or from haematogenous 
seeding from distant sites. While ofloxacin, 
nalidixic acid and cefuroxime were the most 
effective antibiotics invitro for the 
uropathogens in the present study, co-
trimoxazole, ampicillin and piperacillin were 
the least effective. Similar patterns have been 
observed among isolates in different studies on 
HIV infected children and adults (12, 16-27).    
 Leucocyturia is referred to as the 
presence of white blood cells (WBC) in urine, 
which can easily be detected using a dipstick 
urinalysis in a reaction that is based on the 
presence of leucocyte esterase, an enzyme 
found in azurophilic granules of monocytes and 
granulocytes. Bacteria and epithelial cells of 
the urinary tract do not contain esterase hence 
a positive leucocyte esterase test in dipstick 
urinalysis implies an inflammation and not 
necessarily an infection. Leucocyturia is 
abnormal, although some experts believe that 
observation of more than 5 WBC per high 
power field (HPF) is indicative of pathological 
leucocyturia. However, UTI is more likely when 
leucocyturia is associated with bacteriuria. In 
the present study, 35.2% of the subjects with 
isolates in their urine had leucocyturia, an 
association that is strongly in support of UTI. 
This is similar to 33.3% leucocyturia reported 
by Dondo et al (24) among their cohorts.  
 Nitrituria is the presence of nitrite in 
the urine, which is usually absent in normal 
urine. Nitrite is produced by the reductive 
effect of enzyme reductase on nitrate in the 
urine. This enzyme is produced by nitrite 
producing organisms such as Enterobacter, 
Citrobacter, Klebsiella, E. coli, Ps. aeruginosa 
and P mirabilis when present in the urine (35). 
In the present study, nitrituria was seen in 
18.5% of subjects with positive isolates in the 
urine signifying presence of nitrite producing 
organisms which constituted 85.2% of isolates 
 




in urine of subjects in this study. Dondo et al 
(24) in their study however observed only one 
among 21 subjects with isolates in their urine 
to have positive nitrite test, though nitrate 
producing organisms constituted 78.8% of 
isolates in their study.   
 Haematuria is defined as the presence 
of 5 or more red blood cells (RBC) per high 
power field (HPF) in two consecutive fresh, 
centrifuged specimens obtained at least one 
week apart (36). The dipstick urinalysis 
method is the commonest method for 
detection of haematuria in urine and has been 
reported to be 100% sensitive and 99% 
specific in detecting 5-10 RBC/HPF (5-10 
RBC/µl of urine or 0.015 mg/dl of 
haemoglobin). Haematuria can originate from 
any part of the kidney as injury to the uro-
epithelium such as irritation, inflammation or 
invasion by organism can result in haematuria. 
In the present study, 27.8% of subjects with 
isolates in their urine had positive dipstick 
urinalysis. However microscopy was not 
conducted for the presence of red cell cast, 
dysmorphic RBC or acanthocytes to determine 
if the haematuria is of glomerular or tubular 
origin or from other parts of the urinary tract. 
Conclusion 
 
 There is high prevalence of UTI among 
HIV infected children and adolescents on 
outpatient follow up at the University of Abuja 
Teaching Hospital, Abuja, Nigeria. This is more 
likely to occur in subjects with high VL. Routine 
urine screening with dipstick urinalysis and 
culture for evidence of UTI are recommended 
for HIV infected children and adolescents with 




1.  World Health Organization. Treatment of children 
 living with HIV. Global Health Sector Strategy in 
 HIV/AIDS, 2011-2015. Available from: 
 http://www.unaids.org/en/media/unaids/content  
 assets/documents/epidemiology/2012/gr2012/JC4
 34_WorldAIDSd_results_en.pdf. 
2.  UNAIDS. Global report: UNAIDS report on the 
 global AIDS epidemic 2010. Available from: 
 http://www.unaids.org/globalreport/Global_report
 .htm. 
3.  Steel-Duncan, J., Miller, J. M., Pierre, R. B., 
 Dunkley-Thompson. J., Palmer, P., Evans-Gilbert, 
 T., Rodriquez, B., Christie., C. D. C., Kingston 
 Paediatric and Perinatal HIV/AIDS Study Group. 
 Renal manifestations in HIV-infected Jamaican 
 children. West Indian Med J. 2008; 57 (3): 
4.  Ramsuran, D., Bhimma, R., Ramdial, P. K., et al. 
 The spectrum of HIV-related nephropathy in 
 children. Pediatr Nephrol. 2012; 27 (5): 821-827. 
5.  Jian, F., Linda, M., and Shortliffe, D. Urinary tract 
 infection in children: etiology and epidemiology. 
 Urol Clin N Am. 2004; 31: 517–526 
6.  Sharma, S. Current understanding of pathogenic 
 mechanisms in UTI. Ann Natl Acad Med Sci. 1997; 
 33 (1): 31-38. 
7.  Jackson, S. L., Boyko, E. J., Scholes, D., Abraham, 
 L., Gupta, K., and Fihn, S. D. Predictors of urinary 
 tract infection after menopause: a prospective 
 study. Am J Med. 2004; 117 (12): 903–911.  
8.  Nelson, J. M., and Good, E. Urinary tract infections 
 and asymptomatic bacteriuria in older adults. 
 Nurse Pract. 2015; 40 (8): 43–58.  
9.  Foxman, B. Epidemiology of urinary tract 
 infections: incidence, morbidity, and economic 
 costs. Dis Mon. 2003; 49 (2):53–70.  
10.  Mladenovic, J., Veljovic, M., Udovicic, I., et al. 
 Catheter-associated urinary tract infection in a 
 surgical intensive care unit. Vojnosanit Pregl. 
 2015; 72 (10): 883–888.  
11.  Staiman, V. R., and Lowe, F. C. Urologic problems 
 in patients with acquired immunodeficiency 
 syndrome. Scientific World Journal. 2004; 4 Suppl 
 1: 427-437. 
12.   Iweriobor, B. C., Obi, C. L., and Akenyemi, O. 
 Uropathogens isolated from HIV infected patients 
 from Limpopo Province, South Africa. Afr J 
 Biotechnol. 2012; 11: 10598-10604 
13.  Rashmi, K. S., Ravi Kumar, K. I., and 
 Rhagyashree, H. N. Asymptomatic bacteriuria in 
 HIV/AIDS patients: occurrence and risk associated 
 with low CD4 counts. JEMDS. 2013; 2: 3358-
 3360. 
14.  Schonwald, S., Begovae, J., and Skerk, V. Urinary 
 tract infections in HIV disease. Int J Antimicrob 
 Agents. 1999: 309 – 311 
15.  Kaplan, M. S., Wschsler, M., and Benson, M. C. 
 Urologic manifestations of AIDS. Urology. 1978; 
 30: 441 – 443 
16.  Asharam, K., Bhimma, R., and Adhikari, M. 
 Human Immunodeficiency virus and urinary tract 
 infections in children. Ann Trop Paediatr. 2003; 
 23: 273-277 
17.   O’Regan, S., Russo, P., Lapointe, N., and 
 Rousseau, E. AIDS and the urinary tract. J AIDS. 
 1990; 3: 244- 
18.  Ibadin, M. O., Onunu, A., and Ukoh, G. Urinary 
 tract infection in adolescent /young adult 
 Nigerians with acquired human immunodeficiency 
 disease in Benin City. J Med Biomed Res. 2006; 5: 
 55-60. 
19.  Akinsete, A. M., and Ezeaka, C. Prevalence and 
 risk factors of asymptomatic bacteriuria among 
 children living with HIV in Lagos, Nigeria. Pan Afr 
 Med J. 2018; 31: 181.  
20.  Inyang-Etoh, P. C., Udofia, G. C., Alaibe, A. A., et 
 al. Asymptomatic bacteriuria in patients on 
 antiretroviral drug treatment in Calabar. J Med 
 Sci. 2009; 9 (6): 270-275. 
21.  Skrzat-Klapaczyńska, A., Matłosz, M., Bednarska, 
 A., Paciorek, M., Firląg-Burkacka, E., Horban, A., 
 and Kowalska, J. D. Factors associated with 
 urinary tract infections among HIV-1 infected 
 patients. PLoS One. 2018; 13 (1): e0190564.  
22.  Kanu, A. M., Mgbajiaka, N., and Abadom, N. 
 Prevalence of urinary tract infection among HIV 
 patients in Aba, Nigeria. Int J Inf Dis. 2016; 45 
 (1): 229. 
23.  Kemajou, T. S., Ajugwo, A. O., Oshoma, C. E., 
 and Enabulele, O. I. Antibiotic Resistance of 
 Bacterial Isolates from HIV Positive Patients with 
 Urinary Tract Infection (UTI) in PortHarcourt, 
 Nigeria. J AIDS Clin Res. 2016; 7: 594.  
24.  Dondo, V., Mujuru, H. A., Nathoo, J. K., Chirehwa, 
  
 




 M., and Mufandaedza, Z. Renal abnormalities 
 among HIV-infected, antiretroviral naive children, 
 Harare, Zimbabwe: a cross-sectional study. BMC 
 Pediatrics. 2013; 13: 75.  
25.  Nilima, K. R., Gafencu, I. M., Doros, G., Thanki, C. 
 N., Lesovici, M., and Serban, M. Renal 
 Consequences in HIV Infected Children. Jurnalul 
 Pediatrului. 2009; XII: 45-46. 
 26.  Iduoriyekemwen, N. J., Sadoh, W. E., and Sadoh, 
 A. E. Asymptomatic Bacteriuria In HIV positive 
 Nigerian children. JMBR. 2012; 11 (1): 88-94. 
27.  Sheyin, Z. S., Olowolafe, C. O., Essien, U. C., 
 Shindang, J., Ede, F. R., and Bigwan, E. I. 
 Prevalence of Urinary Tract Infection in HIV 
 Patients on Antiretroviral Drugs in Jos Metropolis, 
 Nigeria. World J of Pub Hlth. 2018; 3 (2): 57-60.  
28.  Imamura, A. Approach to opportunistic illness in 
 the HAART era. Nihon Rinsho. 2002; 60 (4): 757-
 762. 
29.   Hoepelman, A., Van Buren, M., Van De Broek, P. 
 J. Bacteriuria in men infected with Human 
 Immunodeficiency Virus-1 is related to their 
 immune status (CD4+ cell count). AIDS. 2012; 6 
 (2): 179-184.  
30.  Klapaczyńska, A. S., Matłosz, B., Bednarska, A., 
 Paciorek, M., Firląg-Burkacka, E., Horban, A., and 

















































 tract infections among HIV-1 infected patients. 
 PLoS One. 2018; 13 (1): e0190564.  
31.  Okechukwu, A. A., and Amajuoyi, F. I.  First and 
 Second Line Highly Active Anti-Retroviral Therapy   
 Failure in HIV Infected Nigerian Children at 
 University of Abuja Teaching Hospital 
 Gwagwalada, Nigeria. HIV Clin Scientific Res. 
 2015; 2 (2): 049-054.  
32. Oladeinde, B. H., Omoregie, R., Olley, M., and 
 Anunibe, J. A. Urinary tract infection in a rural 
 community of Nigeria. N Am J Med Sci. 2011; 3 
 (2): 75–77.  
33.  Sheyin, Z. S., Olowolafe, C, O,, Essien, U. C., 
 Shindang, J., Ede, F. R., and Bigwan, E. I. 
 Prevalence of Urinary Tract Infection in HIV 
 Patients on Antiretroviral Drugs in Jos Metropolis, 
 Nigeria. World J of Pub Hlth. 2018; 3 (2): 57-60.  
34.  Kennedy, T. Rudolph's Pediatrics, 21st Ed, 1667-
 73. Mc-Graw-Hill, New York, 2003. 
35.  Holloway, J. I., Joshi, N., and O'Bryan, T. Positive 
 urine nitrite test: an accurate predictor of absence 
 of pure enterococcal bacteriuria. South Med J. 
 2009; 93 (7): 681-682. 
36.  Jaun, A. M., Catalina, M., Eduardo, G., et al., 
 Haematuria: the forgotten CKD factor?  Nephrol 
 Dial Transplant. 2012; 27 (1): 28-34. 
 
 
 
. 
